Salsalate Oral Tablet for Prophylaxis of Preeclampsia

Phase < 1

Waitlist Available

Led By Anna Stanhewicz, PhD

Research Sponsored by University of Iowa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up a total of 3 times throughout the study (approximately 4 weeks): 1) at the beginning of the study, 2) at the completion of the 5 day placebo treatment, and 3) at the completion of 5 days of oral salsalate treatment

Summary

This trial is investigating why women who develop preeclampsia during pregnancy are more likely to develop cardiovascular disease later in life, in order to identify better clinical management of cardiovascular disease risk in these women.

Eligible Conditions

Prophylaxis of Preeclampsia

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ a total of 3 times throughout the study (approximately 4 weeks): 1) at the beginning of the study, 2) at the completion of the 5 day placebo treatment, and 3) at the completion of 5 days of oral salsalate treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~a total of 3 times throughout the study (approximately 4 weeks): 1) at the beginning of the study, 2) at the completion of the 5 day placebo treatment, and 3) at the completion of 5 days of oral salsalate treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and a total of 3 times throughout the study (approximately 4 weeks): 1) at the beginning of the study, 2) at the completion of the 5 day placebo treatment, and 3) at the completion of 5 days of oral salsalate treatment for reporting.